カテゴリー： QYResearch, 世界

起立性低血圧治療薬の世界市場：規模・現状・予測

QYResearchが発行した調査報告書（DATA909X18788）
◆英語タイトル：Global Orthostatic Hypotension Drugs Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18788
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：90
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※当調査レポートでは、起立性低血圧治療薬の世界市場について調査・分析し、起立性低血圧治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ミドドリン、ノーテラ（ドロキシドパ）、フルドロコルチゾン、その他の薬物）、用途別（病院、医学研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の起立性低血圧治療薬市場動向
・主要企業別マーケットシェア
・起立性低血圧治療薬の種類別市場規模2014-2019
（ミドドリン、ノーテラ（ドロキシドパ）、フルドロコルチゾン、その他の薬物）
・起立性低血圧治療薬の用途別市場規模2014-2019
（病院、医学研究所、クリニック、その他）
・起立性低血圧治療薬の北米市場：主要企業・種類別/用途別市場規模
・起立性低血圧治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・起立性低血圧治療薬の中国市場：主要企業・種類別/用途別市場規模
・起立性低血圧治療薬の日本国内市場：主要企業・種類別/用途別市場規模
・起立性低血圧治療薬の東南アジア市場：主要企業・種類別/用途別市場規模
・起立性低血圧治療薬のインド市場：主要企業・種類別/用途別市場規模
・起立性低血圧治療薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Amneal Pharmaceuticals Inc.、H. Lundbeck AS、Mylan NV、Novartis AG、Pfizer Inc.）
・起立性低血圧治療薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

The increasing prevalence of chronic diseases will also contribute to the growth of the OH drugs market. Orthostatic hypotension is associated with various neurodegenerative diseases, cardiovascular diseases, and diabetes.Orthostatic hypotension is difficult to treat with single-drug therapy because orthostatic stress varies as per the circumstances during the day. Moreover, most of the OH drugs are used to improve postural symptoms, standing time, and function instead of achieving upright normotension that may cause supine hypertension. These factors have boosted the use of a combination of various drugs, such as midodrine and fludrocortisone, midodrine and pyridostigmine, or midodrine and octreotide, for the treatment of symptomatic OH.
In 2018, the global Orthostatic Hypotension Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Orthostatic Hypotension Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orthostatic Hypotension Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Amneal Pharmaceuticals Inc.
H. Lundbeck AS
Mylan NV
Novartis AG
Pfizer Inc.
…

Market segment by Type, the product can be split into
Midodrine
Northera (droxidopa)
Fludrocortisone
Other Drugs

Market segment by Application, split into
Hospital
Medical Research Institute
Clinic
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Orthostatic Hypotension Drugs status, future forecast, growth opportunity, key market and key players.
To present the Orthostatic Hypotension Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Orthostatic Hypotension Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Orthostatic Hypotension Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Midodrine
1.4.3 Northera (droxidopa)
1.4.4 Fludrocortisone
1.4.5 Other Drugs
1.5 Market by Application
1.5.1 Global Orthostatic Hypotension Drugs Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Medical Research Institute
1.5.4 Clinic
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Orthostatic Hypotension Drugs Market Size
2.2 Orthostatic Hypotension Drugs Growth Trends by Regions
2.2.1 Orthostatic Hypotension Drugs Market Size by Regions (2019-2025)
2.2.2 Orthostatic Hypotension Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Orthostatic Hypotension Drugs Market Size by by Players
3.1.1 Global Orthostatic Hypotension Drugs Revenue by by Players (2014-2019)
3.1.2 Global Orthostatic Hypotension Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Orthostatic Hypotension Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Orthostatic Hypotension Drugs Key Players Head office and Area Served
3.3 Key Players Orthostatic Hypotension Drugs Product/Solution/Service
3.4 Date of Enter into Orthostatic Hypotension Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Orthostatic Hypotension Drugs Market Size by Type (2014-2019)
4.2 Global Orthostatic Hypotension Drugs Market Size by Application (2014-2019)

5 North America
5.1 North America Orthostatic Hypotension Drugs Market Size (2014-2019)
5.2 Orthostatic Hypotension Drugs Key Players in North America
5.3 North America Orthostatic Hypotension Drugs Market Size by Type
5.4 North America Orthostatic Hypotension Drugs Market Size by Application

6 Europe
6.1 Europe Orthostatic Hypotension Drugs Market Size (2014-2019)
6.2 Orthostatic Hypotension Drugs Key Players in Europe
6.3 Europe Orthostatic Hypotension Drugs Market Size by Type
6.4 Europe Orthostatic Hypotension Drugs Market Size by Application

7 China
7.1 China Orthostatic Hypotension Drugs Market Size (2014-2019)
7.2 Orthostatic Hypotension Drugs Key Players in China
7.3 China Orthostatic Hypotension Drugs Market Size by Type
7.4 China Orthostatic Hypotension Drugs Market Size by Application

8 Japan
8.1 Japan Orthostatic Hypotension Drugs Market Size (2014-2019)
8.2 Orthostatic Hypotension Drugs Key Players in Japan
8.3 Japan Orthostatic Hypotension Drugs Market Size by Type
8.4 Japan Orthostatic Hypotension Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Orthostatic Hypotension Drugs Market Size (2014-2019)
9.2 Orthostatic Hypotension Drugs Key Players in Southeast Asia
9.3 Southeast Asia Orthostatic Hypotension Drugs Market Size by Type
9.4 Southeast Asia Orthostatic Hypotension Drugs Market Size by Application

10 India
10.1 India Orthostatic Hypotension Drugs Market Size (2014-2019)
10.2 Orthostatic Hypotension Drugs Key Players in India
10.3 India Orthostatic Hypotension Drugs Market Size by Type
10.4 India Orthostatic Hypotension Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Orthostatic Hypotension Drugs Market Size (2014-2019)
11.2 Orthostatic Hypotension Drugs Key Players in Central & South America
11.3 Central & South America Orthostatic Hypotension Drugs Market Size by Type
11.4 Central & South America Orthostatic Hypotension Drugs Market Size by Application

12 International Players Profiles
12.1 Amneal Pharmaceuticals Inc.
12.1.1 Amneal Pharmaceuticals Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Orthostatic Hypotension Drugs Introduction
12.1.4 Amneal Pharmaceuticals Inc. Revenue in Orthostatic Hypotension Drugs Business (2014-2019))
12.1.5 Amneal Pharmaceuticals Inc. Recent Development
12.2 H. Lundbeck AS
12.2.1 H. Lundbeck AS Company Details
12.2.2 Company Description and Business Overview
12.2.3 Orthostatic Hypotension Drugs Introduction
12.2.4 H. Lundbeck AS Revenue in Orthostatic Hypotension Drugs Business (2014-2019)
12.2.5 H. Lundbeck AS Recent Development
12.3 Mylan NV
12.3.1 Mylan NV Company Details
12.3.2 Company Description and Business Overview
12.3.3 Orthostatic Hypotension Drugs Introduction
12.3.4 Mylan NV Revenue in Orthostatic Hypotension Drugs Business (2014-2019)
12.3.5 Mylan NV Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Orthostatic Hypotension Drugs Introduction
12.4.4 Novartis AG Revenue in Orthostatic Hypotension Drugs Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 Pfizer Inc.
12.5.1 Pfizer Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Orthostatic Hypotension Drugs Introduction
12.5.4 Pfizer Inc. Revenue in Orthostatic Hypotension Drugs Business (2014-2019)
12.5.5 Pfizer Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Orthostatic Hypotension Drugs Key Market Segments
Table Key Players Orthostatic Hypotension Drugs Covered
Table Global Orthostatic Hypotension Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Midodrine Figures
Table Key Players of Midodrine
Figuer Northera (droxidopa) Figures
Table Key Players of Northera (droxidopa)
Figuer Fludrocortisone Figures
Table Key Players of Fludrocortisone
Figuer Other Drugs Figures
Table Key Players of Other Drugs
Table Global Orthostatic Hypotension Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Orthostatic Hypotension Drugs Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Medical Research Institute Case Studies
Figure Clinic Case Studies
Figure Other Case Studies
Figure Orthostatic Hypotension Drugs Report Years Considered
Figure Global Orthostatic Hypotension Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Orthostatic Hypotension Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Orthostatic Hypotension Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Orthostatic Hypotension Drugs Market Share by Regions 2014-2019
Figure Global Orthostatic Hypotension Drugs Market Share by Regions 2014-2019
Figure Global Orthostatic Hypotension Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Orthostatic Hypotension Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Orthostatic Hypotension Drugs Market Share by by Players (2014-2019)
Figure Global Orthostatic Hypotension Drugs Market Share by by Players in 2018
Table Global Orthostatic Hypotension Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Orthostatic Hypotension Drugs Product/Solution/Service
Table Date of Enter into Orthostatic Hypotension Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Orthostatic Hypotension Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Orthostatic Hypotension Drugs Market Size Share by Type (2014-2019)
Figure Global Orthostatic Hypotension Drugs Market Size Market Share by Type (2014-2019)
Table Global Orthostatic Hypotension Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Orthostatic Hypotension Drugs Market Size Share by Application (2014-2019)
Figure Global Orthostatic Hypotension Drugs Market Size Market Share by Application (2014-2019)
Figure Global Orthostatic Hypotension Drugs Revenue Market Share by Application in 2018
Figure North America Orthostatic Hypotension Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Orthostatic Hypotension Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Orthostatic Hypotension Drugs Market Share (2018-2019)
Table North America Orthostatic Hypotension Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Orthostatic Hypotension Drugs Market Share by Type 2014-2019
Table North America Orthostatic Hypotension Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Orthostatic Hypotension Drugs Market Share by Application 2014-2019
Figure Europe Orthostatic Hypotension Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Orthostatic Hypotension Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Orthostatic Hypotension Drugs Market Share (2018-2019)
Table Europe Orthostatic Hypotension Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Orthostatic Hypotension Drugs Market Share by Type 2014-2019
Table Europe Orthostatic Hypotension Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Orthostatic Hypotension Drugs Market Share by Application 2014-2019
Figure China Orthostatic Hypotension Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Orthostatic Hypotension Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Orthostatic Hypotension Drugs Market Share (2018-2019)
Table China Orthostatic Hypotension Drugs Market Size by Type 2014-2019 (Million US$)
Table China Orthostatic Hypotension Drugs Market Share by Type 2014-2019
Table China Orthostatic Hypotension Drugs Market Size by Application 2014-2019 (Million US$)
Table China Orthostatic Hypotension Drugs Market Share by Application 2014-2019
Figure Japan Orthostatic Hypotension Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Orthostatic Hypotension Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Orthostatic Hypotension Drugs Market Share (2018-2019)
Table Japan Orthostatic Hypotension Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Orthostatic Hypotension Drugs Market Share by Type 2014-2019
Table Japan Orthostatic Hypotension Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Orthostatic Hypotension Drugs Market Share by Application 2014-2019
Figure Southeast Asia Orthostatic Hypotension Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Orthostatic Hypotension Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Orthostatic Hypotension Drugs Market Share (2018-2019)
Table Southeast Asia Orthostatic Hypotension Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Orthostatic Hypotension Drugs Market Share by Type 2014-2019
Table Southeast Asia Orthostatic Hypotension Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Orthostatic Hypotension Drugs Market Share by Application 2014-2019
Figure India Orthostatic Hypotension Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Orthostatic Hypotension Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Orthostatic Hypotension Drugs Market Share (2018-2019)
Table India Orthostatic Hypotension Drugs Market Size by Type 2014-2019 (Million US$)
Table India Orthostatic Hypotension Drugs Market Share by Type 2014-2019
Table India Orthostatic Hypotension Drugs Market Size by Application 2014-2019 (Million US$)
Table India Orthostatic Hypotension Drugs Market Share by Application 2014-2019
Figure Central & South America Orthostatic Hypotension Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Orthostatic Hypotension Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Orthostatic Hypotension Drugs Market Share (2018-2019)
Table Central & South America Orthostatic Hypotension Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Orthostatic Hypotension Drugs Market Share by Type 2014-2019
Table Central & South America Orthostatic Hypotension Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Orthostatic Hypotension Drugs Market Share by Application 2014-2019
Table Amneal Pharmaceuticals Inc. Company Details
Table Amneal Pharmaceuticals Inc. Revenue in Orthostatic Hypotension Drugs Business 2014-2019 (Million US$)
Figure Amneal Pharmaceuticals Inc. Revenue Growth Rate in Orthostatic Hypotension Drugs Business (2014-2019)
Table Amneal Pharmaceuticals Inc. Recent Development
Table H. Lundbeck AS Company Details
Table H. Lundbeck AS Revenue in Orthostatic Hypotension Drugs Business 2014-2019 (Million US$)
Figure H. Lundbeck AS Revenue Growth Rate in Orthostatic Hypotension Drugs Business (2014-2019)
Table H. Lundbeck AS Recent Development
Table Mylan NV Company Details
Table Mylan NV Revenue in Orthostatic Hypotension Drugs Business 2014-2019 (Million US$)
Figure Mylan NV Revenue Growth Rate in Orthostatic Hypotension Drugs Business (2014-2019)
Table Mylan NV Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Orthostatic Hypotension Drugs Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Orthostatic Hypotension Drugs Business (2014-2019)
Table Novartis AG Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Orthostatic Hypotension Drugs Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Orthostatic Hypotension Drugs Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Global Orthostatic Hypotension Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Orthostatic Hypotension Drugs Market Size Share by Regions (2019-2025)
Figure Global Orthostatic Hypotension Drugs Market Size Share by Regions in 2025
Figure North America Orthostatic Hypotension Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Orthostatic Hypotension Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Orthostatic Hypotension Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Orthostatic Hypotension Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Orthostatic Hypotension Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Orthostatic Hypotension Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Orthostatic Hypotension Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Orthostatic Hypotension Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Orthostatic Hypotension Drugs Market Size by Product (2019-2025)
Figure Global Orthostatic Hypotension Drugs Market Size by Product in 2025
Table Global Orthostatic Hypotension Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Orthostatic Hypotension Drugs Market Size by Application (2019-2025)
Figure Global Orthostatic Hypotension Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Amneal Pharmaceuticals Inc.、H. Lundbeck AS、Mylan NV、Novartis AG、Pfizer Inc.

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 起立性低血圧治療薬の世界市場：規模・現状・予測(Global Orthostatic Hypotension Drugs Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の測量システム産業：成長傾向・競合分析
  • 世界の高電圧スイッチ断路器産業：成長傾向・競合分析
  • 世界のワックス研磨機市場
  • 世界のスチレンブタジエンラテックス市場
  • 世界の残留電流デバイス市場
  • 世界の取り外し可能ボラード市場
  • 世界のペントサンポリ硫酸ナトリウム市場
  • 世界の台座ファン市場
  • 世界の医療用アルミ箔市場
  • 世界のハイブリッドワイヤレススピーカー市場
  • 世界の光ファイバー光線治療機器市場
  • 世界の耐食性キャスター市場
  • 世界の臍帯血幹細胞市場
  • 世界の竹原料市場
  • 世界の袋詰め機市場